Advertisement

Topics

Solexa Limited Company Profile

19:10 EDT 24th September 2017 | BioPortfolio

Solexa is developing a breakthrough technology for DNA sequencing. Its Single Molecule Arrays (SMAs) promise the powerful combination of massively parallel sequencing with amplification-free ‘one pot’ sample preparation. The output of the system will be used to reassemble individual genomic sequence in the context of a reference sequence, providing a TotalGenotypeä, essentially all sequence differences between an individual sample and a reference sequence. Solexa’s long-term goal is to perform a TotalGenotypeä in less than a day and for a few $k.

Solexa plans to overcome the current economic and throughput roadblocks inhibiting genome-wide analysis of genetic variation for disease-gene discovery, pharmacogenetics and genetic profiling. It intends initially to focus on information-based services, products and discovery collaborations using an in-house analytical capability.

Location

Chesterford Research Park, Little Chesterford
Nr. Saffron Waldon
Essex
CB10 1XL
United Kingdom

Contact

Phone: +44 (0) 1799 532300
Fax: +44 (0) 1799 532301
Email: info@solexa.co.uk


News Articles [13 Associated News Articles listed on BioPortfolio]

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Jefferies 2017 Global Healthcare Conference

JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results

Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...

Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies

Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Molecular Cloning and Characterization of Carotenoid Pathway Genes and Carotenoid Content in Ixeris dentata var. albiflora.

Ixeris dentata var. albiflora is considered as a potential therapeutic agent against mithridatism, calculous, indigestion, pneumonia, hepatitis, and tumors as well as good seasoned vegetable in Far Ea...

Comparative transcription analysis of different Antirrhinum phyllotaxy nodes identifies major signal networks involved in vegetative-reproductive transition.

Vegetative-reproductive phase change is an indispensable event which guarantees several aspects of successful meristem behaviour and organ development. Antirrhinum majus undergoes drastic changes of s...

Classical swine fever virus Shimen infection increases p53 signaling to promote cell cycle arrest in porcine alveolar macrophages.

Classical swine fever virus (CSFV) replicates in macrophages and causes persistent infection. Despite its role in disastrous economic losses in swine industries, the molecular mechanisms underlying it...

Comparative transcriptomic analysis of key genes involved in flavonoid biosynthetic pathway and identification of a flavonol synthase from Artemisia annua L.

(1) The regulation mechanism of flavonoids, which were found to synergize anti-malarial and anti-cancer compounds in Artemisia annua, is still unclear. (2) In this study, an anthocyanidin-accumulating...

Identification and analysis of the expression of microRNA from lactating and nonlactating mammary glands of the Chinese swamp buffalo.

To study the role of microRNA (miR) in the lactation physiology of water buffalo, 2 multiparous dairy buffaloes (including an 8-yr-old buffalo that had been lactating for 3 mo, as well as a 10-yr-old ...

Clinical Trials [0 Results]

None

Companies [86 Associated Companies listed on BioPortfolio]

Solexa Limited

Solexa is developing a breakthrough technology for DNA sequencing. Its Single Molecule Arrays (SMAs) promise the powerful combination of massively parallel sequencing with amplification-free ‘one po...

Solexa Ltd.

Solexa, Inc. is developing and preparing to commercialize a new platform designed to perform a range of analyses including whole genome resequencing, gene expression analysis and micro-RNA analysis. T...

Solexa Inc.

Solexa, Inc. is developing and preparing to commercialize a new platform designed to perform a range of analyses including whole genome resequencing, gene expression analysis and micro-RNA analysis. T...

Solexa Inc

Solexa, Inc. is developing and preparing to commercialize a new platform designed to perform a range of analyses including whole genome resequencing, gene expression analysis and micro-RNA analysis. T...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

More Information about "Solexa Limited" on BioPortfolio

We have published hundreds of Solexa Limited news stories on BioPortfolio along with dozens of Solexa Limited Clinical Trials and PubMed Articles about Solexa Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Solexa Limited Companies in our database. You can also find out about relevant Solexa Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record